Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies. Corvus focuses on bringing medicines to patients with the most difficult-to-treat cancers. Corvus is headquartered in Burlingame, California.
Last updated on
About Corvus Pharmaceuticals
Founded
2014Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$244MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
541714Location
City
BurlingameState
CaliforniaCountry
United StatesTech Stack (30)
